Literature DB >> 20434038

18 years surgical experience with mediastinal mature teratoma.

Chin-Chih Chang1, Yih-Leong Chang, Jang-Ming Lee, Jin-Shing Chen, Hsao-Hsun Hsu, Pei-Ming Huang, Yung-Chie Lee.   

Abstract

BACKGROUND/
PURPOSE: Few studies have examined the surgical outcomes of mediastinal mature teratoma in Taiwan. In the present study, the clinicopathological characteristics of mature teratoma and their impact on surgical outcome were analyzed.
METHODS: From 1988 to 2005, 57 cases of mediastinal mature teratoma were reviewed. We collected and analyzed data about patient age, sex, symptoms, blood sugar, pulmonary function, diagnosis, tumor size, histopathological features, operative methods, operative time, tumor adhesion, blood loss, ventilator requirement, intensive care unit stay, chest tube requirement, and postoperative hospital stay.
RESULTS: There were 18 male and 39 female patients with a median age of 27 years. Forty-three patients received conventional open surgery, whereas 14 received video-assisted thoracoscopic surgery. The patients in the thoracoscopic group had a decreased operative time (106.4 +/- 35.7 min vs. 205.4 +/- 75.7 min, p = 0.038), fewer ventilator days (0.2 +/- 0.4 vs. 0.5 +/- 0.8, p = 0.034), and a shorter stay in the intensive care unit (0.6 +/- 0.8 days vs. 1.5 +/- 1.4 days, p = 0.030). Pancreatic tissue was identified in 21 of 57 tumors (36.8%). The patients with tumors that contained pancreatic tissue had more presenting symptoms and complicated surgery than those whose tumors were without pancreatic tissue (76.2%vs. 33.3%, p = 0.002, and 42.9%vs. 11.1%, p = 0.008). The patients with symptoms had a higher incidence of complicated surgery than those without (39.3%vs. 6.9%, p = 0.004).
CONCLUSION: Mediastinal mature teratoma commonly occurs in young women. Thoracoscopic surgery is a feasible technique for mediastinal mature teratoma resection if no dense adhesions are found during preoperative assessment. The presence of symptoms might be a relative contraindication for thoracoscopic teratoma resection because of its association with surgical complications. (c) 2010 Formosan Medical Association & Elsevier. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20434038     DOI: 10.1016/S0929-6646(10)60054-X

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  6 in total

1.  Experience with thoracoscopic resection for mediastinal mature teratoma: a retrospective analysis of 15 patients.

Authors:  Yasushi Shintani; Soichiro Funaki; Tomoyuki Nakagiri; Masayoshi Inoue; Noriyoshi Sawabata; Masato Minami; Yoshihisa Kadota; Meinoshin Okumura
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-03

2.  Mediastinal lesions across the age spectrum: a clinicopathological comparison between pediatric and adult patients.

Authors:  Tingting Liu; Lika'a Fasih Y Al-Kzayer; Xiao Xie; Hua Fan; Shamil Naji Sarsam; Yozo Nakazawa; Lei Chen
Journal:  Oncotarget       Date:  2017-04-18

3.  Thoracoscopic surgery approach to mediastinal mature teratomas: a single-center experience.

Authors:  Lu Huu Pham; Diep Ke Trinh; Anh Viet Nguyen; Lanh Sy Nguyen; Dung Thanh Le; Dinh-Hoa Nguyen; Hung Quoc Doan; Uoc Huu Nguyen
Journal:  J Cardiothorac Surg       Date:  2020-02-12       Impact factor: 1.637

4.  Giant mature teratoma in thymic tissue removed with uniportal vats approach.

Authors:  F Carannante; L Frasca; V Marziali; F Longo; P Crucitti
Journal:  Int J Surg Case Rep       Date:  2019-11-27

5.  Surgical management of primary mediastinal mature teratoma: A single-center 20 years' experience.

Authors:  Zhedong Zhang; Xun Wang; Zuli Zhou; Guanchao Jiang; Yun Li
Journal:  Front Surg       Date:  2022-09-05

6.  Compression of superior vena cava and azygos vein by a giant mediastinal mature cystic teratoma: a case report.

Authors:  Qian Luo; Wendong Qu; Cheng Chen; Yang Liu; Yating Wei; Yongxiang Song; Xixian Ke
Journal:  Transl Cancer Res       Date:  2021-10       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.